| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | integrin binding | 2.64e-03 | 175 | 9 | 2 | GO:0005178 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.74e-05 | 124 | 9 | 3 | GO:0007229 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.76e-04 | 270 | 9 | 3 | GO:0007160 | |
| GeneOntologyBiologicalProcess | aorta development | 5.25e-04 | 80 | 9 | 2 | GO:0035904 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 5.65e-04 | 83 | 9 | 2 | GO:0060976 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 5.99e-04 | 410 | 9 | 3 | GO:0031589 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 6.79e-04 | 91 | 9 | 2 | GO:0033627 | |
| GeneOntologyBiologicalProcess | embryo implantation | 7.71e-04 | 97 | 9 | 2 | GO:0007566 | |
| GeneOntologyBiologicalProcess | artery development | 1.44e-03 | 133 | 9 | 2 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.46e-03 | 134 | 9 | 2 | GO:0003279 | |
| GeneOntologyBiologicalProcess | heart development | 3.50e-03 | 757 | 9 | 3 | GO:0007507 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 3.61e-03 | 212 | 9 | 2 | GO:0003205 | |
| GeneOntologyBiologicalProcess | limb development | 4.02e-03 | 224 | 9 | 2 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 4.02e-03 | 224 | 9 | 2 | GO:0048736 | |
| GeneOntologyBiologicalProcess | female pregnancy | 4.94e-03 | 249 | 9 | 2 | GO:0007565 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 5.91e-03 | 273 | 9 | 2 | GO:0030323 | |
| GeneOntologyBiologicalProcess | blood vessel development | 6.24e-03 | 929 | 9 | 3 | GO:0001568 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 6.64e-03 | 290 | 9 | 2 | GO:0044703 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 6.82e-03 | 294 | 9 | 2 | GO:0044706 | |
| GeneOntologyBiologicalProcess | vasculature development | 7.02e-03 | 969 | 9 | 3 | GO:0001944 | |
| GeneOntologyCellularComponent | integrin complex | 8.12e-05 | 32 | 9 | 2 | GO:0008305 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.78e-04 | 59 | 9 | 2 | GO:0098636 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.24e-03 | 656 | 9 | 3 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.26e-03 | 658 | 9 | 3 | GO:0030312 | |
| MousePheno | abnormal diaphragm central tendon morphology | 2.21e-06 | 4 | 9 | 2 | MP:0012061 | |
| MousePheno | pulmonary hypoplasia | 4.50e-06 | 54 | 9 | 3 | MP:0001178 | |
| MousePheno | abnormal diaphragm development | 2.86e-05 | 13 | 9 | 2 | MP:0012251 | |
| MousePheno | small lung | 4.39e-05 | 115 | 9 | 3 | MP:0003641 | |
| MousePheno | abnormal thoracic aorta morphology | 6.94e-05 | 134 | 9 | 3 | MP:0010468 | |
| MousePheno | diaphragmatic hernia | 1.48e-04 | 29 | 9 | 2 | MP:0003924 | |
| MousePheno | abnormal lung size | 1.51e-04 | 174 | 9 | 3 | MP:0004881 | |
| MousePheno | abnormal tendon morphology | 1.70e-04 | 31 | 9 | 2 | MP:0005503 | |
| MousePheno | abnormal aorta morphology | 3.22e-04 | 225 | 9 | 3 | MP:0000272 | |
| MousePheno | abnormal xiphoid process morphology | 3.60e-04 | 45 | 9 | 2 | MP:0000159 | |
| MousePheno | abnormal pulmonary artery morphology | 5.98e-04 | 58 | 9 | 2 | MP:0000484 | |
| MousePheno | abnormal esophagus morphology | 7.74e-04 | 66 | 9 | 2 | MP:0000467 | |
| MousePheno | abnormal systemic artery morphology | 7.76e-04 | 304 | 9 | 3 | MP:0011655 | |
| MousePheno | abnormal heart position or orientation | 9.72e-04 | 74 | 9 | 2 | MP:0006065 | |
| MousePheno | abnormal diaphragm morphology | 1.08e-03 | 78 | 9 | 2 | MP:0002279 | |
| MousePheno | atrioventricular septal defect | 1.25e-03 | 84 | 9 | 2 | MP:0010412 | |
| MousePheno | abnormal muscle development | 1.34e-03 | 87 | 9 | 2 | MP:0000733 | |
| MousePheno | abnormal atrioventricular septum morphology | 1.34e-03 | 87 | 9 | 2 | MP:0010592 | |
| MousePheno | abnormal caudal vertebrae morphology | 1.34e-03 | 87 | 9 | 2 | MP:0002759 | |
| MousePheno | abnormal limb bud morphology | 1.46e-03 | 91 | 9 | 2 | MP:0005650 | |
| MousePheno | syndactyly | 1.53e-03 | 93 | 9 | 2 | MP:0000564 | |
| MousePheno | abnormal artery morphology | 2.26e-03 | 440 | 9 | 3 | MP:0002191 | |
| MousePheno | abnormal aortic arch morphology | 2.49e-03 | 119 | 9 | 2 | MP:0004113 | |
| MousePheno | abnormal respiratory system morphology | 2.70e-03 | 1027 | 9 | 4 | MP:0002132 | |
| MousePheno | polydactyly | 2.92e-03 | 129 | 9 | 2 | MP:0000562 | |
| MousePheno | abnormal limb development | 3.42e-03 | 140 | 9 | 2 | MP:0006279 | |
| MousePheno | abnormal hypaxial muscle morphology | 3.47e-03 | 141 | 9 | 2 | MP:0003358 | |
| MousePheno | double outlet right ventricle | 3.92e-03 | 150 | 9 | 2 | MP:0000284 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 5.87e-03 | 1269 | 9 | 4 | MP:0011111 | |
| Domain | EGF_extracell | 1.74e-06 | 60 | 8 | 3 | IPR013111 | |
| Domain | EGF_2 | 1.74e-06 | 60 | 8 | 3 | PF07974 | |
| Domain | INTEGRIN_BETA | 5.77e-06 | 9 | 8 | 2 | PS00243 | |
| Domain | Integrin_bsu | 5.77e-06 | 9 | 8 | 2 | IPR015812 | |
| Domain | EGF | 1.05e-04 | 235 | 8 | 3 | SM00181 | |
| Domain | EGF-like_dom | 1.25e-04 | 249 | 8 | 3 | IPR000742 | |
| Domain | EGF_1 | 1.34e-04 | 255 | 8 | 3 | PS00022 | |
| Domain | EGF_2 | 1.50e-04 | 265 | 8 | 3 | PS01186 | |
| Domain | PSI | 1.51e-04 | 44 | 8 | 2 | IPR016201 | |
| Domain | PSI | 1.65e-04 | 46 | 8 | 2 | SM00423 | |
| Domain | EGF-like_CS | 5.15e-03 | 261 | 8 | 2 | IPR013032 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.81e-04 | 61 | 7 | 2 | M27103 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 8.29e-04 | 90 | 7 | 2 | M631 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.59e-03 | 258 | 7 | 2 | MM14572 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.83e-03 | 300 | 7 | 2 | M610 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 1.91e-06 | 100 | 9 | 3 | 25807483 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.92e-05 | 248 | 9 | 3 | 24006456 | |
| Pubmed | Transcriptional analysis of cleft palate in TGFβ3 mutant mice. | 3.53e-05 | 35 | 9 | 2 | 32913205 | |
| GeneFamily | CD molecules|Integrin beta subunits | 3.30e-06 | 9 | 6 | 2 | 1159 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 8.15e-05 | 767 | 9 | 4 | M39209 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 2.09e-04 | 64 | 9 | 2 | M2572 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_A_UP | 3.69e-04 | 85 | 9 | 2 | M7517 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 4.13e-04 | 90 | 9 | 2 | M38984 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 4.22e-04 | 91 | 9 | 2 | M40180 | |
| Coexpression | CAHOY_ASTROGLIAL | 5.10e-04 | 100 | 9 | 2 | M2807 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 6.73e-04 | 115 | 9 | 2 | M45752 | |
| Coexpression | SENESE_HDAC3_TARGETS_DN | 6.95e-04 | 548 | 9 | 3 | M16859 | |
| Coexpression | TRAVAGLINI_LUNG_ARTERY_CELL | 8.72e-04 | 131 | 9 | 2 | M41662 | |
| Coexpression | GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_DN | 9.53e-04 | 137 | 9 | 2 | M8915 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_STROMAL_CELLS | 1.23e-03 | 156 | 9 | 2 | M40151 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 1.34e-03 | 163 | 9 | 2 | M2769 | |
| Coexpression | GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP | 1.38e-03 | 165 | 9 | 2 | M6880 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | 1.41e-03 | 699 | 9 | 3 | M4960 | |
| Coexpression | GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 1.53e-03 | 174 | 9 | 2 | M6877 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 1.60e-03 | 178 | 9 | 2 | M17079 | |
| Coexpression | ESC_V6.5_UP_LATE.V1_DN | 1.64e-03 | 180 | 9 | 2 | M2771 | |
| Coexpression | GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP | 1.84e-03 | 191 | 9 | 2 | M4164 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP | 1.90e-03 | 194 | 9 | 2 | M4189 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP | 1.90e-03 | 194 | 9 | 2 | M4187 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP | 1.92e-03 | 195 | 9 | 2 | M4195 | |
| Coexpression | GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN | 1.92e-03 | 195 | 9 | 2 | M3252 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP | 1.95e-03 | 197 | 9 | 2 | M4975 | |
| Coexpression | GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN | 1.95e-03 | 197 | 9 | 2 | M8431 | |
| Coexpression | GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_DN | 1.95e-03 | 197 | 9 | 2 | M8339 | |
| Coexpression | GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP | 1.95e-03 | 197 | 9 | 2 | M4167 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP | 1.95e-03 | 197 | 9 | 2 | M4993 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 1.97e-03 | 198 | 9 | 2 | MM17083 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_DN | 1.99e-03 | 199 | 9 | 2 | M5159 | |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M9774 | |
| Coexpression | JIANG_HYPOXIA_NORMAL | 2.01e-03 | 200 | 9 | 2 | M3996 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M3068 | |
| Coexpression | GSE13229_IMM_VS_MATURE_NKCELL_DN | 2.01e-03 | 200 | 9 | 2 | M3207 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_DC_DN | 2.01e-03 | 200 | 9 | 2 | M5400 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 2.05e-03 | 202 | 9 | 2 | M38982 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.06e-04 | 234 | 9 | 3 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.13e-06 | 152 | 9 | 3 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-06 | 181 | 9 | 3 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-06 | 181 | 9 | 3 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-06 | 181 | 9 | 3 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.37e-06 | 182 | 9 | 3 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.37e-06 | 182 | 9 | 3 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.55e-06 | 184 | 9 | 3 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.55e-06 | 184 | 9 | 3 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.92e-06 | 188 | 9 | 3 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.92e-06 | 188 | 9 | 3 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.61e-06 | 195 | 9 | 3 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.81e-06 | 197 | 9 | 3 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 198 | 9 | 3 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.02e-06 | 199 | 9 | 3 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 199 | 9 | 3 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.02e-06 | 199 | 9 | 3 | e9009eee7f77b9c9917f8e0e723001d9e76eb553 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.02e-06 | 199 | 9 | 3 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.13e-06 | 200 | 9 | 3 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.13e-06 | 200 | 9 | 3 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.13e-06 | 200 | 9 | 3 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.13e-06 | 200 | 9 | 3 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.13e-06 | 200 | 9 | 3 | 74ad0ae592252060ee294d7483327d765a6ba1dd | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 3.27e-04 | 137 | 9 | 2 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Glioblastoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.32e-04 | 138 | 9 | 2 | 142e4692d7f97ce157ed70fcb2e4a63febfbb6e4 | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Glioblastoma-Primary_GBM|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.32e-04 | 138 | 9 | 2 | 728e0576526c4525ba2038921425ab3e7d321ce2 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-04 | 139 | 9 | 2 | 505bf5a483fc2ba69377db9850c3b26ab2f416d1 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.56e-04 | 143 | 9 | 2 | 92ddc3e3f6ba78dd9daeb272c12503ec2650a874 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.61e-04 | 144 | 9 | 2 | fca32b38d23fa4d213e553b929604a2796e9a929 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.71e-04 | 146 | 9 | 2 | c0e1836845c083bf9d88a620da27acbfdea9fb20 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 148 | 9 | 2 | dfd3f2c4b884ea9e23831a242a89ac985b409640 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.86e-04 | 149 | 9 | 2 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.91e-04 | 150 | 9 | 2 | 1270f33f9d7e46e55adf1a96e8beee858b95589d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.91e-04 | 150 | 9 | 2 | 156118ce1d69522624196410cba18b8354cd0bb4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.07e-04 | 153 | 9 | 2 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.18e-04 | 155 | 9 | 2 | cd7d95cbcad248670e531d80bb83c55e36ebc573 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.29e-04 | 157 | 9 | 2 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.29e-04 | 157 | 9 | 2 | 70fd6c46db4250c7de5c4686a9500689402737f6 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.29e-04 | 157 | 9 | 2 | dd08dc19d434e94a194076c462ee273c682abf55 | |
| ToppCell | Basal_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.34e-04 | 158 | 9 | 2 | 51e3ed1b91b010404d66e3e7efdbffc0c815e25b | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.34e-04 | 158 | 9 | 2 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | Club_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.40e-04 | 159 | 9 | 2 | a7bcff268b1962a561fd2848e01ae16565bce895 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-04 | 162 | 9 | 2 | bfaeff19bb56598fdc8c82be71d51787cf13928f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.56e-04 | 162 | 9 | 2 | 25bb1b9709f960fdf90faff56e874f52a8f5d17e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.68e-04 | 164 | 9 | 2 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.68e-04 | 164 | 9 | 2 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.68e-04 | 164 | 9 | 2 | 3d8ff70fe5582d1fb56b338be8b76fa1428b3657 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.79e-04 | 166 | 9 | 2 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-04 | 167 | 9 | 2 | 5fc85a05124cd2324e1b8ff940193880f83cd8af | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-04 | 167 | 9 | 2 | f01b96173deda0239fa482989873cf308e49d48c | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 167 | 9 | 2 | a4a795751644b22af616335379e64ae95175180c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.85e-04 | 167 | 9 | 2 | f4943fb5001475ddab82a0273bcbb3fa68fdd7bd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-04 | 168 | 9 | 2 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.90e-04 | 168 | 9 | 2 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.96e-04 | 169 | 9 | 2 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.96e-04 | 169 | 9 | 2 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-04 | 170 | 9 | 2 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-04 | 170 | 9 | 2 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-04 | 170 | 9 | 2 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-04 | 170 | 9 | 2 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-04 | 170 | 9 | 2 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-04 | 171 | 9 | 2 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-04 | 171 | 9 | 2 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 172 | 9 | 2 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.14e-04 | 172 | 9 | 2 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 172 | 9 | 2 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.14e-04 | 172 | 9 | 2 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.20e-04 | 173 | 9 | 2 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.20e-04 | 173 | 9 | 2 | b0ff9808e38cb64a734ced498cd0546728746cd5 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.20e-04 | 173 | 9 | 2 | 3a9e9a09b3eeb37cbe56d650e112a8398879477f | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 5.20e-04 | 173 | 9 | 2 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.32e-04 | 175 | 9 | 2 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.32e-04 | 175 | 9 | 2 | 36cb3c8116bd467ee5da0630d8b3d3e4afcc2ded | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.38e-04 | 176 | 9 | 2 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.38e-04 | 176 | 9 | 2 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.38e-04 | 176 | 9 | 2 | 27e6b3ae41068d6cfdda3d46da7df2a27567140e | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.38e-04 | 176 | 9 | 2 | d6a5470af9592f34a741265f2ea9651c05c3add3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-04 | 177 | 9 | 2 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-04 | 177 | 9 | 2 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.44e-04 | 177 | 9 | 2 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-04 | 177 | 9 | 2 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.44e-04 | 177 | 9 | 2 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.44e-04 | 177 | 9 | 2 | d68132e145bd413404fdbe215b5dbe520e756e50 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-04 | 177 | 9 | 2 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-04 | 177 | 9 | 2 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-04 | 177 | 9 | 2 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.50e-04 | 178 | 9 | 2 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.50e-04 | 178 | 9 | 2 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.50e-04 | 178 | 9 | 2 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-04 | 178 | 9 | 2 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.50e-04 | 178 | 9 | 2 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-MEP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.50e-04 | 178 | 9 | 2 | b8c301d65c0f37941e8e9414d55e90edb6ecc195 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 179 | 9 | 2 | 6f51a4580c06fc55cc764052c9b26f7c55660282 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.56e-04 | 179 | 9 | 2 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 179 | 9 | 2 | a6ce1fa338d4905bd6afef00763ac83e916a0b37 | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.56e-04 | 179 | 9 | 2 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 179 | 9 | 2 | f14440f6ce9b4fcdd4bcb2488b949f9a0e17bc23 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-04 | 179 | 9 | 2 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.56e-04 | 179 | 9 | 2 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.63e-04 | 180 | 9 | 2 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.63e-04 | 180 | 9 | 2 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| Drug | Butirosin disulfate salt [51022-98-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 5.31e-05 | 199 | 9 | 3 | 6080_UP | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; HL60; HT_HG-U133A | 5.39e-05 | 200 | 9 | 3 | 3030_UP | |
| Drug | oxypertine | 1.62e-04 | 49 | 9 | 2 | CID000004640 | |
| Drug | AC1L1UVI | 2.04e-04 | 55 | 9 | 2 | CID000061263 | |
| Drug | tetrathiomolybdate | 4.11e-04 | 78 | 9 | 2 | ctd:C020809 | |
| Drug | 4-hydroxytestosterone | 4.11e-04 | 78 | 9 | 2 | CID000160615 | |
| Drug | gamma-butyrolactone | 7.85e-04 | 108 | 9 | 2 | CID000007302 | |
| Drug | Simvastatin | 1.24e-03 | 581 | 9 | 3 | ctd:D019821 | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Up 200; 15uM; PC3; HT_HG-U133A | 1.86e-03 | 167 | 9 | 2 | 6677_UP | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 2.30e-03 | 186 | 9 | 2 | 2684_UP | |
| Drug | fisetin; Up 200; 50uM; PC3; HG-U133A | 2.42e-03 | 191 | 9 | 2 | 579_UP | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 7376_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 4289_DN | |
| Drug | Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 7220_DN | |
| Drug | (+,-)-Synephrine [94-07-5]; Up 200; 24uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 3578_UP | |
| Drug | Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 3200_DN | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 5909_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 4284_DN | |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 3795_DN | |
| Drug | Verteporfin [129497-78-5]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 3556_UP | |
| Drug | 5186324; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 2.53e-03 | 195 | 9 | 2 | 900_UP | |
| Drug | Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 3173_DN | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 3452_UP | |
| Drug | Glycopyrrolate [596-51-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 3427_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 3930_UP | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 1629_DN | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; HL60; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 3042_UP | |
| Disease | response to hydrochlorothiazide, fasting blood glucose measurement | 6.62e-05 | 46 | 8 | 2 | EFO_0004465, EFO_0005202 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 7.52e-05 | 49 | 8 | 2 | EFO_0006954, EFO_1001069 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGYYADEDSNRCAHC | 1506 | Q92824 | |
| GAECARYRACTDAAY | 406 | Q2M1P5 | |
| CSFRDEDDDCTYSYT | 671 | P16144 | |
| AASDDRCYRYADCAS | 661 | Q5VV63 | |
| RCYRYADCASCTANT | 666 | Q5VV63 | |
| EDTSCDYGYHRRFAC | 326 | P28300 | |
| CDERDCRAVYDRYSD | 271 | O95965 | |
| CRAVYDRYSDDFCSG | 276 | O95965 | |
| ETYCRAATEYARACS | 356 | Q3ZCN5 | |
| CFNDADSRLRYYACE | 101 | Q08AM6 | |
| YSAYIRRCACAASSD | 31 | Q5I0X7 |